๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II evaluation of piroxantrone in renal cell carcinoma

โœ Scribed by Ace Allen; Michael Wolf; E. David Crawford; Mellar P. Davis; Ronald B. Natale; Margaret L. Barnett

Publisher
Springer US
Year
1992
Tongue
English
Weight
263 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II evaluation of amonafide in rena
Phase II evaluation of amonafide in renal cell carcinoma
โœ Celestia S. Higano; Phyllis Goodman; John B. Craig; Julie A. Kish; Saul E. Rivki ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer US ๐ŸŒ English โš– 205 KB

Twenty four patients with advanced renal cell carcinoma were treated in a phase II trial with amonafide 300-450 mg/m2/day on days 1-5 every 21 days. There were no responders, 6 patients had stable disease, 14 experienced progressive disease and 4 were assumed to be non-responders as no evaluation wa